TABIIY DORI VOSITALARININGSINTETIK DORI VOSITALARIDAN FARQI
Ключевые слова:
tabiiy dorilar, sintetik dorilar, farmakologiya, xalq tabobati, klinik sinovlar, dori ta’siri, nojo‘ya holatlar.Аннотация
Ushbu maqolada tabiiy va sintetik dorilarning o‘zaro farqlari, afzalliklari hamda kamchiliklari ilmiy jihatdan tahlil qilinadi. Shuningdek ushbu ikki turdagi dorilarning inson organizmiga ta’siri, nojo‘ya ta’sirlari, dozalash aniqligi va ilmiy asoslanganligi jihatidan solishtirma tahlil keltirilgan. Misollar, statistik ma’lumotlar va ilmiy manbalar asosida mavzuning dolzarbligi yoritilgan.
Библиографические ссылки
Wang X. et al. Multi-target mechanisms of QiShenYiQi for myocardial infarction based on network pharmacology. https://pubmed.ncbi.nlm.nih.gov/24817581/
Huang J. et al. Potential multi-target treatment of Alzheimer’s disease usingSelaginella.https://www.frontiersin.org/articles/10.3389/fphar.2017.00539/full
Kongkaew, C., Phan, D. T. A., Janusorn, P., & Mongkhon, P. (2024). Estimating Adverse Events Associated With Herbal Medicines Using Pharmacovigilance Databases: Systematic Review and Meta-Analysis. JMIR Public Health and Surveillance, 10(1), e63808.https://pubmed.ncbi.nlm.nih.gov/39208414/
Gafner S. (2020). Challenges in ensuring quality of herbal dietary supplements.https://www.herbalgram.org/resources/herbalgram/issues/127/table-of-contents/hg127-herbquality/
World Health Organization (WHO).WHO Guidelines on Good Agricultural and Collection Practices (GACP) for Medicinal Plants.https://apps.who.int/iris/handle/10665/42783
Kongkaew C. et al. (2024). Estimating Adverse Events Associated With Herbal Medicines Using Pharmacovigilance Databases. https://pubmed.ncbi.nlm.nih.gov/39208414/
Gafner, S. (2020).Challenges in ensuring quality of herbal dietary supplements – HerbalGram. https://www.herbalgram.org/resources/herbalgram/issues/127/table-of-contents/hg127-herbquality
FDA (U.S. Food and Drug Administration).Drug Development and Approval Process. https://www.fda.gov/drugs/development-approval-process-drugs
WHO Model List of Essential Medicines (2023). https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2023.01
